课题基金 / 基金详情

Ultrasound Imaging Investigation of Resistance and Adaptation to Targeted Anti-cancer Therapeutics

Ultrasound Imaging Investigation of Resistance and Adaptation to Targeted Anti-cancer Therapeutics
靶向抗癌治疗的耐药性和适应性的超声成像研究
批准号：
267755
负责人：
Burns Peter N
金额：
$42.21万
依托单位：
Sunnybrook Research Institute (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-09-01 至 2017-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=267755&lang=en
关键词：
Antiangiogenic Therapy Blood Flow Imaging Contrast Ultrasound Imaging Drug Resistance Dynamic Contrast Enhanced Imaging Imaging Cancer Biomarkers Tumour Angiogensis Ultrasound Imaging

项目摘要

项目成果

Burns Peter N的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A new class of therapies target the developing (or 'angiogenic') blood vessels of a cancer, which both deliver oxygen and nutrients essential for tumour growth and provide a pathway for its metastatic spread. Antiangiogenic drugs inhibit the signals that
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of next generation ultrasound imaging
Acoustically activated submicron droplets of liquid perfluorocarbon as a new contrast agent for ultrasound imaging
海外基金